Bicyclic compound and use thereof for medical purposes
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 4, 2023
Grant Date -
Jun 10, 2021
app pub date -
Jan 14, 2021
filing date -
Jul 28, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Since a compound represented by the general formula (I) (wherein definition of each group is as described in the specification), a salt thereof, a solvate thereof, or a prodrug thereof has strong and sustaining intraocular pressure lowering activity and, further, has no side effect on eyes such as ocular stimulating property (hyperemia, corneal clouding etc.), aqueous humor protein rise etc., it has high safety, and can be an excellent agent for preventing and/or treating glaucoma etc.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully